The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer

Tumor biopsy is the gold standard for the assessment of clinical biomarkers for treatment. However, tumors change dynamically in response to therapy, and there remains a need for a more representative biomarker that can be assayed over the course of treatment. Circulating tumor cells (CTCs) may prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulasinghe, Arutha, Kapeleris, Joanna, Kimberley, Rebecca, Mattarollo, Stephen R., Thompson, Erik W., Thiery, Jean‐Paul, Kenny, Liz, O’Byrne, Ken, Punyadeera, Chamindie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308060/
https://www.ncbi.nlm.nih.gov/pubmed/30565869
http://dx.doi.org/10.1002/cam4.1832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308060/
https://www.ncbi.nlm.nih.gov/pubmed/30565869
http://dx.doi.org/10.1002/cam4.1832

Ejemplares similares